What one share of Alkermes plc. holds
Alkermes plc is a global biopharmaceutical company that seeks to develop innovative medicines in the field of neuroscience. We have a portfolio of proprietary commercial products for the treatment of alcohol dependence, opioid dependence, schizophrenia, bipolar I disorder and narcolepsy, and a pipeline of clinical and preclinical candidates in development for neurological disorders.
Alkermes plc.’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $9.94 |
|---|---|
| Profit | $0.39 |
| Capex (buildings and equipment) | $0.18 |
| Free cash flow | $1.32 |
| Cash and investments | $3.05 |
| Debt | $8.97 |
| Book value | $10.79 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2010 | $1.88 | −$0.42 | $0.17 | −$0.30 | — | $4.35 |
| 2011 | $1.95 | −$0.48 | $0.10 | −$0.16 | — | $4.10 |
| 2012 | $3.40 | −$0.99 | $0.15 | −$0.17 | — | $6.56 |
| 2013 | $4.20 | $0.18 | $0.16 | $0.76 | — | $7.12 |
| 2013 | $4.14 | $0.14 | — | — | — | $7.73 |
| 2014 | $4.26 | −$0.21 | $0.23 | −$0.15 | — | $9.47 |
| 2015 | $4.21 | −$1.52 | $0.35 | −$0.62 | — | $8.72 |
| 2016 | $4.92 | −$1.38 | $0.29 | −$0.71 | — | $7.93 |
| 2017 | $5.89 | −$1.03 | $0.33 | −$0.21 | — | $7.81 |
| 2018 | $7.05 | −$0.90 | $0.45 | $0.19 | — | $7.52 |
| 2019 | $7.46 | −$1.25 | $0.58 | −$0.12 | — | $6.88 |
| 2020 | $6.54 | −$0.70 | $0.27 | $0.26 | — | $6.70 |
| 2021 | $7.12 | −$0.29 | $0.17 | $0.45 | — | $6.87 |
| 2022 | $6.79 | −$0.97 | $0.23 | −$0.11 | — | $6.35 |
| 2023 | $9.80 | $2.10 | $0.28 | $2.08 | — | $7.20 |
| 2024 | $9.21 | $2.17 | $0.20 | $2.40 | — | $9.03 |
| 2025 | $8.75 | $1.43 | $0.24 | $2.85 | — | $10.99 |
Common questions about Alkermes plc.
How much does one share of Alkermes plc. earn?
Over the last 12 months, each share of Alkermes plc. earned $0.39 of profit on $9.94 of sales, keeping about 4¢ of every $1 (profit margin).
Does Alkermes plc. pay a dividend?
Alkermes plc. didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Alkermes plc.’s book value per share?
Alkermes plc.’s book value is $10.79 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Alkermes plc. have?
Each share of Alkermes plc. has $3.05 of cash and investments and $8.97 of debt, as of June 30, 2026.
What is Alkermes plc.’s free cash flow per share?
$1.32 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
Has Alkermes plc. bought back shares?
Alkermes plc.’s share count rose about 78% from 2010 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.